By admin 
The American Diabetes Association (ADA) has officially concluded an internal investigation into the controversial removal of five of its members from the 82nd Scientific Sessions in New Orleans, finding that the organization did not engage in the silencing of protest or the improper use of law enforcement. The findings, released via a five-person committee audit on Tuesday evening, represent an attempt by the ADA leadership to close a turbulent chapter that has shadowed the organization since June. However, the report’s conclusion—that the ejections were a matter of administrative policy rather than content-based censorship—appears to have done little to mollify critics who see the incident as a sign of growing friction between medical societies and the researchers they represent.
The incident at the heart of the investigation occurred on June 5, 2022, during one of the most high-profile gatherings in the global diabetes research calendar. As attendees gathered to hear a keynote address from the acting director of the National Institutes of Health (NIH), five prominent members of the ADA began distributing physical copies of an editorial titled "Misguided Brushes of a Pen Continue to Dismantle." The piece, which had been published on April 29 in the ADA’s own peer-reviewed journal, Diabetes Care, offered a scathing critique of federal funding shifts that the authors argued were undermining the infrastructure of diabetes research in the United States.
The authors of the editorial, including Dr. Franck Mauvais-Jarvis of Tulane University and other esteemed clinicians, expressed grave concerns regarding the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and its recent funding trajectories. They argued that "misguided" administrative decisions were resulting in the dismantling of essential research programs, potentially setting back the search for cures and advanced treatments by years. By handing out copies of this published work outside the hall where the NIH leadership was slated to speak, the members intended to bring direct attention to what they characterized as a crisis in scientific support.
According to the ADA’s internal review committee, the decision to eject these members was not a reaction to the substance of their critique. Instead, the committee concluded that the action was a standard enforcement of the conference’s established code of conduct. The ADA’s policies strictly prohibit the distribution of any printed materials—whether promotional, educational, or editorial—in certain restricted areas of the convention center without prior authorization. The review stated that the members were warned that their actions violated these protocols and were asked to stop. When they continued to distribute the papers, security personnel escorted them from the premises and revoked their credentials for the remainder of the event.
Crucially, the internal audit flatly rejected claims that local police were involved in the ejections. In the immediate aftermath of the June incident, reports circulated among attendees and on social media suggesting that the New Orleans Police Department (NOPD) had been called to remove the scientists, an optic that many found distressing. The ADA review clarified that the personnel involved were private security contractors hired by the association and the convention center. The report emphasized that the process followed standard operating procedures for managing non-compliant attendees and that no criminal charges or formal police interventions took place.
The five-person committee responsible for the audit was selected by the ADA’s board of directors and tasked with examining the timeline of events, the communication between staff and the ejected members, and the consistency of policy application. While the committee’s findings have been sent to the ADA board for final action, the report has already reignited a debate regarding the "corporate" nature of modern medical conferences. Critics argue that while technical rules regarding the distribution of fliers exist to prevent commercial "spamming" by pharmaceutical representatives, applying those same rules to scientists sharing peer-reviewed research from the organization’s own journal is an overreach.
The controversy is inextricably linked to the broader anxiety surrounding the funding of diabetes research. The National Institutes of Health, specifically through the NIDDK, is the primary engine for diabetes innovation in the United States. In recent years, researchers have voiced frustration over a "flat" budget that has failed to keep pace with inflation or the increasing prevalence of both Type 1 and Type 2 diabetes. Furthermore, a shift in NIDDK strategy toward large-scale consortiums and away from individual investigator-initiated (R01) grants has left many mid-career scientists struggling to maintain their laboratories.
The editorial that sparked the protest, "Misguided Brushes of a Pen," highlighted how these funding shifts are particularly damaging to clinical research centers. The authors argued that the "dismantling" of certain programs was not based on a lack of scientific merit but on administrative "brushes of a pen" that prioritized new initiatives over proven, long-standing research infrastructure. By attempting to hand this editorial to the NIH director, the protesters were attempting to force a dialogue on the very floor of the conference intended to showcase their work.
The ADA, however, maintains that a scientific session—which hosts upwards of 12,000 attendees—requires strict adherence to logistics to ensure safety and the professional flow of information. The association’s press release noted that there are "appropriate channels" for dissent and discussion, including the very journal that published the editorial. The review committee argued that allowing unauthorized distribution of materials would set a precedent that could lead to chaos at future events, potentially allowing for political or commercial interference that would detract from the scientific mission.
The fallout from the ejections has created a rift within the ADA membership. Some members have expressed solidarity with the ejected researchers, viewing the ADA’s response as "heavy-handed" and "antithetical to the spirit of scientific inquiry." There is a perception among some rank-and-file members that the ADA leadership is more concerned with maintaining a smooth relationship with federal agencies and corporate sponsors than with advocating for the gritty, often difficult needs of laboratory and clinical researchers.
Conversely, some members of the ADA leadership and long-term organizers believe the rules are necessary. They point out that the Scientific Sessions are a massive undertaking involving millions of dollars in investment and that the code of conduct is signed by every attendee upon registration. From this perspective, the five members were not being "silenced" because of their ideas—which were already in the public domain via Diabetes Care—but were being penalized for a clear and willful violation of a contract they agreed to when they purchased their badges.
The internal review’s failure to quell the controversy highlights a larger trend in the medical community: the tension between "Big Science" organizations and individual advocacy. As the ADA moves forward, it faces the challenge of repairing its reputation among researchers who feel that the organization has become too bureaucratic. The board of directors is expected to review the committee’s suggestions, which may include updates to the code of conduct to better define "unauthorized materials" or the creation of designated "free speech zones" at future conferences to prevent a repeat of the New Orleans incident.
As the data from the internal audit is digested by the wider medical community, the focus remains on the precarious state of diabetes research funding. While the ADA has cleared itself of procedural wrongdoing, the underlying grievances that led to the protest remain unresolved. The "misguided brushes" described in the editorial continue to be a point of contention for scientists who fear that without a significant increase in federal support and a more transparent allocation process, the next generation of diabetes breakthroughs may be delayed or lost entirely.
The ADA’s Scientific Sessions are intended to be a celebration of progress and a collaborative environment for the world’s leading experts. However, the shadow of the New Orleans ejections serves as a reminder that the politics of funding and the protocols of professional societies are often as complex and contentious as the science itself. For now, the ADA board holds the report, and the scientific community waits to see if the organization will take steps to bridge the gap with its frustrated members or if the divide will continue to widen as the 2023 sessions approach. Regardless of the audit’s findings, the image of world-class researchers being escorted from their own professional home remains a potent symbol of the current frictions in the American scientific landscape.
